Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention

In 2019/2020, the emergence of coronavirus disease 2019 (COVID‐19) resulted in rapid increases in infection rates as well as patient mortality. Treatment options addressing COVID‐19 included drug repurposing, investigational therapies such as remdesivir, and vaccine development. Combination therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Aynur, Wang, Boqian, Qian, Feng, Kee, Theodore, Blasiak, Agata, Ong, Yoong Hun, Hooi, Lissa, Parekh, Falgunee, Soriano, Rafael, Olinger, Gene G., Keppo, Jussi, Hardesty, Chris L., Chow, Edward K., Ho, Dean, Ding, Xianting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235487/
https://www.ncbi.nlm.nih.gov/pubmed/32838027
http://dx.doi.org/10.1002/adtp.202000034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235487/
https://www.ncbi.nlm.nih.gov/pubmed/32838027
http://dx.doi.org/10.1002/adtp.202000034

Ejemplares similares